In this study, products A, B, and D were analyzed using program (1), and products C and E analyzed using program (2).
For the purpose of this study, products that were deemed breakthrough and substantial improvement were termed 'significant therapeutic advance' and products in other groups were termed 'no therapeutic advance'.
For the purpose of this study, products that were deemed as breakthrough and with substantial improvement were termed as 'innovative' and products in other categories were termed 'not innovative'.
This is contrasted to study product use, which requires persistence through the full length of the trial to determine safety and efficacy.
In this study, existing product information, such as the dimensions, characteristics and design and application criteria, of a product was analyzed.
In this study, higher product yield was achieved by using the auto-induction process for production of cIFN-α protein in E. coli.
In this study, green product designs and remanufacturing efforts are investigated when we develop an integrated production inventory model with short life-cycles.
To avoid PCR product sizes at 250 bp that would be difficult to size correctly with the DNA standard (LIZ500), in this study PCR product size was set to 90 210 bp or 270 400 bp.
In this study, the product design stage is highlighted through a case study of gasoline blends with bio-based chemicals.
This study analyzed product styles by applying genetic algorithms and Kansei Engineering Type II (AHP and Quantification Theory Type I).
Compared to the one before this study, the product's ee was improved from 82.1 to 92.3%, and the reaction yield was enhanced from 77.3 to 82.3%.
